The rapid and cost-effective development of innovative therapeutics and treatments is critical not just to public health, but to the functioning of society and economic activity. Leading drug developers, as well as their partners across the research, development, and manufacturing value chain, count on our deep expertise in biopharma’s capital-raising and deal-making landscape.

We serve clients that operate across a broad range of therapeutic areas, including oncology, immunology, neurology, rare disease, genetic medicines, liver disease, and other specialty pharma areas.